Journal Watch · Frontiers in Immunology · 2026

<i>Orientia tsutsugamushi</i> and <i>Epstein-Barr Virus</i> coinfection presenting with transient fluctuating hearing loss: a case report.

The immunological interplay between these pathogens warrants further investigation.

Zhai Y, Yu M, Cheng L et al.Frontiers in Immunology3 min readPharma relevance 40/100

DOI: 10.3389/fimmu.2026.1750100PMID: 41972180Study type: case report / series

TL;DR

The immunological interplay between these pathogens warrants further investigation.

Key findings

  • This case highlights a rare presentation of scrub typhus with EBV coinfection involving fluctuating hearing loss.
  • The dramatic response to doxycycline suggests this auditory symptom may be a reversible, immune-mediated complication of <i>O. tsutsugamushi</i> infection.
  • Physicians should be aware of this potential manifestation in endemic areas.
  • The immunological interplay between these pathogens warrants further investigation.

What they did

Laboratory findings indicated hepatic impairment and systemic inflammation. Metagenomic next-generation sequencing (mNGS) of cerebrospinal fluid detected <i>O. tsutsugamushi</i> and EBV. EBV serology profile (VCA-IgG+, VCA-IgM-, EBNA-IgG+) suggested viral reactivation. The patient failed to respond to initial beta-lactam antibiotic therapy but showed rapid and complete resolution of symptoms, including hearing loss, after initiation of doxycycline. At the 1-month and 3-month follow-up, audiological assessment confirmed normal hearing.

Full abstract (original)

Background: Scrub typhus, caused by the obligate intracellular bacterium <i>Orientia tsutsugamushi</i>(<i>O. tsutsugamushi</i>), is an acute febrile illness. While neurological complications are known, hearing loss is an uncommon manifestation, and coinfection with <i>Epstein-Barr virus</i>(EBV) presents unique diagnostic and pathophysiological challenges. A 58-year-old woman presented with a 5-day history of high fever, severe headache, and constitutional symptoms. She reported transient, fluctuating bilateral hearing loss. Examination revealed characteristic eschars on her legs.

What they did: Laboratory findings indicated hepatic impairment and systemic inflammation. Metagenomic next-generation sequencing (mNGS) of cerebrospinal fluid detected <i>O. tsutsugamushi</i> and EBV. EBV serology profile (VCA-IgG+, VCA-IgM-, EBNA-IgG+) suggested viral reactivation. The patient failed to respond to initial beta-lactam antibiotic therapy but showed rapid and complete resolution of symptoms, including hearing loss, after initiation of doxycycline. At the 1-month and 3-month follow-up, audiological assessment confirmed normal hearing.

Results & conclusions: This case highlights a rare presentation of scrub typhus with EBV coinfection involving fluctuating hearing loss. The dramatic response to doxycycline suggests this auditory symptom may be a reversible, immune-mediated complication of <i>O. tsutsugamushi</i> infection. Physicians should be aware of this potential manifestation in endemic areas. The immunological interplay between these pathogens warrants further investigation.

Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1750100 · PubMed 41972180.

Why it matters for pharma & biotech

  • Relevant to Immunology teams tracking Frontiers in Immunology for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Frontiers in Immunology study find?

The immunological interplay between these pathogens warrants further investigation.

What type of study is this?

It is a case report / series, published in Frontiers in Immunology in 2026. Laboratory findings indicated hepatic impairment and systemic inflammation.

Where can I read the original paper?

The original is at the publisher via DOI 10.3389/fimmu.2026.1750100. PubMed ID: 41972180. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Zhai Y, Yu M, Cheng L et al.. &lt;i&gt;Orientia tsutsugamushi&lt;/i&gt; and &lt;i&gt;Epstein-Barr Virus&lt;/i&gt; coinfection presenting with transient fluctuating hearing loss: a case report.. Frontiers in Immunology (2026). DOI: 10.3389/fimmu.2026.1750100.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/lt-i-gt-orientia-tsutsugamushi-lt-i-gt-and-lt-i-gt-epstein-barr-virus-lt-750100/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides